Caribou Biosciences (CRBU) Receivables - Net (2020 - 2025)
Caribou Biosciences (CRBU) has disclosed Receivables - Net for 6 consecutive years, with $69000.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net fell 73.96% to $69000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $69000.0 through Dec 2025, down 73.96% year-over-year, with the annual reading at $69000.0 for FY2025, 73.96% down from the prior year.
- Receivables - Net for Q4 2025 was $69000.0 at Caribou Biosciences, down from $242000.0 in the prior quarter.
- The five-year high for Receivables - Net was $1.5 million in Q1 2023, with the low at $2000.0 in Q2 2021.
- Average Receivables - Net over 5 years is $466368.4, with a median of $265000.0 recorded in 2024.
- The sharpest move saw Receivables - Net soared 26100.0% in 2022, then tumbled 90.4% in 2025.
- Over 5 years, Receivables - Net stood at $1.2 million in 2021, then crashed by 82.48% to $202000.0 in 2022, then decreased by 26.73% to $148000.0 in 2023, then surged by 79.05% to $265000.0 in 2024, then crashed by 73.96% to $69000.0 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods came in at $69000.0, $242000.0, and $71000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.